Psychedelic Therapy Market Surges Toward $10 Billion Future
The psychedelic drugs market is poised for explosive growth, with projections going from $3.63 billion in 2024 to $10.11 billion
Read More
The psychedelic drugs market is poised for explosive growth, with projections going from $3.63 billion in 2024 to $10.11 billion
Read More
Bryan Johnson, the biohacking entrepreneur known for his extreme anti-aging protocols, said he will test psilocybin as a longevity therapy.
Read More
Federal officials are signaling growing momentum behind psychedelic drug development. The flood of applications reflects broad enthusiasm.
Read More
A new PET imaging study provides the first direct evidence that ketamine normalizes AMPA receptor density in the brains of
Read More
Researchers combined more than 500 scans and found that psychedelics all pushed the brain toward a similar pattern of activity.
Read More
The 5 best ketamine clinics in Boulder (2026), verified for cannabis-assisted KAP, IOP-integrated Stellate Ganglion Block + IV + IM
Read More
Researchers found that people diagnosed with hallucinogen persisting perception disorder, or HPPD, had higher rates of anxiety.
Read More
North Carolina could become one of the first states in the South to fund psychedelic therapy research.
Read More
The VA began enrolling 240 veterans in a phase 3 psilocybin trial on August 3. There is no placebo arm,
Read More
Compass Pathways plans to launch COMP360 through existing Spravato sites. We counted our directory: 492 clinics carry Spravato, while 1,179
Read More